Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Hepatology. 2020 Dec 19;73(3):1074–1087. doi: 10.1002/hep.31393

TABLE 4.

The SCOPE Index

Value
Attribute Traditional Units SI Units Points
mg/dL μmol/L
Total bilirubin ≤0.6 ≤11 0
0.7–2.7 11.1–46.7 +1
2.8–4.8 46.8–82.4 +2
≥4.9 ≥82.5 +3
g/dL g/L
Albumin ≥4 ≥40 0
3.2–3.9 32–39 +1
≤3.1 ≤31 +2
×103/μL ×109/L
Platelet count ≥225 ≥225 0
136–224 136–224 +1
≤135 ≤135 +2
U/L U/L
GGT ≤100 ≤100 0
101–249 101–249 +2
≥250 ≥250 +3
Cholangiography* Normal 0
Large-duct involvement + 1
Total
Low risk 0–3
Medium risk 4–5
High risk 6–11

The index is the sum of the points attributed to each of the patient’s total bilirubin, albumin, and platelet count.

*

Positive findings of multifocal large-duct beading and strictures on magnetic resonance or endoscopic retrograde cholangiopancreatography.